Home >> Pharmaceuticals >> Food & Beverage >>

Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 23 | Code: MRS - 18294

Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Esperance Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Esperance Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Esperance Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Esperance Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Esperance Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Esperance Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Esperance Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Esperance Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Esperance Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Esperance Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Esperance Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Esperance Pharmaceuticals, Inc. Snapshot 4
Esperance Pharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
Esperance Pharmaceuticals, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Esperance Pharmaceuticals, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Esperance Pharmaceuticals, Inc. - Pipeline Products Glance 9
Esperance Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Esperance Pharmaceuticals, Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Esperance Pharmaceuticals, Inc. - Drug Profiles 11
EP-100 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
EP-200 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
EP-300 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
EP-400 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Esperance Pharmaceuticals, Inc. - Pipeline Analysis 16
Esperance Pharmaceuticals, Inc. - Pipeline Products by Target 16
Esperance Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 17
Esperance Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 18
Esperance Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 19
Esperance Pharmaceuticals, Inc. - Dormant Projects 20
Esperance Pharmaceuticals, Inc. - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

List of Tables
Esperance Pharmaceuticals, Inc., Key Information 4
Esperance Pharmaceuticals, Inc., Key Facts 4
Esperance Pharmaceuticals, Inc. - Pipeline by Indication, 2015 6
Esperance Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 7
Esperance Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 8
Esperance Pharmaceuticals, Inc. - Phase II, 2015 9
Esperance Pharmaceuticals, Inc. - Preclinical, 2015 10
Esperance Pharmaceuticals, Inc. - Pipeline by Target, 2015 16
Esperance Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 17
Esperance Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 18
Esperance Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 19
Esperance Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 20

List of Figures
Esperance Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015 5
Esperance Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 7
Esperance Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 8
Esperance Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015 16
Esperance Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015 17
Esperance Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015 18
Esperance Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 19

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing